SCB-01A

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSCB-01A
Drug Alias Name6-Methoxy-3-(3',4',5'-trimethoxybenzoyl) indoleSB01SB-01DBPR104SCB-01A +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumoursHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSyncore Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyncore Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and Neck

Other Information

ATC CodeN/A
Related LinksN/A